ask="21.23"
ask_size="100"
average_daily_volume="73080"
bid="N/A"
bid_size="N/A"
book_value="-91.82"
change="-0.43"
change_from_200_day_moving_average="4.78"
change_from_50_day_moving_average="1.97"
change_from_52_week_high="-3.72"
change_From_52_week_low="8.35"
change_in_percent="-2.06%"
close="20.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-41.42"
ebitda="-20.24M"
eps_estimate_current_year="-2.50"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.93"
ex_dividend_date="N/A"
float_shares="8852000"
high="20.95"
high_52_weeks="24.12"
last_trade_date="3/3/2017"
last_trade_price="20.40"
last_trade_size="3497"
last_trade_time="4:00pm"
low="20.07"
low_52_weeks="12.05"
market_capitalization="459.94M"
moving_average_200_day="15.62"
moving_average_50_day="18.43"
name="Ra Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.50"
open="20.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+30.62%"
percent_change_from_50_day_moving_average="+10.69%"
percent_change_from_52_week_high="-15.42%"
percent_change_from_52_week_low="+69.28%"
previous_close="20.83"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="81.69"
revenue="5.75M"
shares_outstanding="22546000"
short_ratio="5.52"
stock_exchange="NGM"
symbol="RARX"
volume="23710"
weeks_range_52="12.05 - 24.12"
